Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction

Acute generalized exanthematous pustulosis (AGEP) is a rare and severe cutaneous drug reaction, most often triggered by antibiotics or antifungals. Psychotropic medications are an uncommon cause. We report the case of a 60-year-old male who developed AGEP within 24-48 hours of initiating flupentixol-melitracen, a fixed-dose antipsychotic-antidepressant combination. Clinical features included widespread sterile pustules on an erythematous base, and histopathology confirmed the diagnosis. The eruption resolved rapidly upon drug withdrawal and topical corticosteroids. To the best of our knowledge, this is the first reported case of AGEP induced by flupentixol-melitracen. Clinicians should consider this rare association when evaluating drug-induced pustular eruptions.

Authors

Institutions

Publication Details

Journal
International Journal of Basic & Clinical Pharmacology
Published
2025-08-22
DOI
https://doi.org/10.18203/2319-2003.ijbcp20252588
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction

Asok Gangopadhyay, Dipanjan Das, Lairenjam Teza
International Journal of Basic & Clinical Pharmacology
Drug-Induced Adverse Reactions
article

Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction

Asok Gangopadhyay, Dipanjan Das, Lairenjam Teza
article en

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare and severe cutaneous drug reaction, most often triggered by antibiotics or antifungals. Psychotropic medications are an uncommon cause. We report the case of a 60-year-old male who developed AGEP within 24-48 hours of initiating flupentixol-melitracen, a fixed-dose antipsychotic-antidepressant combination. Clinical features included widespread sterile pustules on an erythematous base, and histopathology confirmed the diagnosis. The eruption resolved rapidly upon drug withdrawal and topical corticosteroids. To the best of our knowledge, this is the first reported case of AGEP induced by flupentixol-melitracen. Clinicians should consider this rare association when evaluating drug-induced pustular eruptions.

International Journal of Basic & Clinical PharmacologyVol. 14(5)
Jagannath University (IN)
Openalex Percentile: Top 75%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Acute generalized exanthematous pustulosis induced by flupentixol-melitracen: a previously unreported drug reaction — Asok Gangopadhyay, Dipanjan Das, et al. · International Journal of Basic & Clinical Pharmacology (2025) | TGRS Research Map | TGRS